Komori
Japan Tissue Engineering (7774) · InitiativeAdvanced

A new management structure leveraging the partnership with FUJIFILM and strengthened execution capabilities

First written in FY2017-Q2. 4 of 5 entries say "Advanced", first in FY2018-Q2. Latest entry: FY2025.

5entries
10years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2018-Q2 – FY20252016: 12017: 120172018: 020182019: 120192020: 120202021: 020212022: 020222023: 020232024: 020242025: 12025
Same theme, other companies
Strengthening the management structure and execution based on collaboration with FujifilmA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2025AdvancedAnnual report

    「June 2025 Representative Director, President and Executive Officer of the Company (incumbent)」

    In June 2025, Yamada Kazuto (山田一登) became Representative Director, President and Executive Officer, marking a change in the presidency to a person with in-house experience in research and development, quality control and reliability assurance, among other areas.
  2. FY2020AdvancedAnnual report

    「June 2020 Representative Director, President and Executive Officer of the Company (incumbent)」

    Akiyama Masataka (秋山雅孝), who became president in June 2019, became a director, and Hata Kenichiro (畠賢一郎) became Representative Director, President and Executive Officer effective June 2020.
  3. FY2019AdvancedAnnual report

    「June 2019 Representative Director, President and Executive Officer of the Company (incumbent)」

    Akiyama Masataka (秋山雅孝), a FUJIFILM veteran, became Representative Director, President and Executive Officer in June 2019, resulting in a change in the management structure.
  4. FY2018-Q2AdvancedAnnual report

    「Representative Director, President and Executive Officer - Director and Senior Managing Executive Officer - Hata Kenichiro (畠 賢一郎) 1 November 2017」

    Effective 1 November 2017, after the end of the quarter, the president and executive officer changed from Hiruma Aiichiro (比留間愛一郎), Representative Director, President and Executive Officer, to Hata Kenichiro (畠賢一郎), who assumed the position, while Hiruma Aiichiro (比留間愛一郎) became a director.
  5. FY2017-Q2First statedAnnual report

    「Against this backdrop, in June 2016, we appointed FUJIFILM veteran Hiruma Aiichiro (比留間愛一郎) as Representative Director, President and Executive Officer. Under the new management structure, we are strengthening execution capabilities by leveraging our strong ties with FUJIFILM and increasing the frequency of management meetings, among other measures.」

    The appointment of a FUJIFILM veteran as president, use of the relationship with FUJIFILM and strengthened execution capabilities through more frequent management meetings are presented as new management initiatives.
Moved together

"Promoting the adoption of alternatives to animal testing using cultured human tissues for research" moved the same way as this thread, in the same document, in 4 of its 5 moves.

433222★123456
  1. ★This thread
  2. 1Promoting the adoption of alternatives to animal testing using cultured human tissues for research4×
  3. 2Wider adoption of the autologous cultured cartilage JACC procedure and expansion of certified facilities authorized to perform it3×
  4. 3Conducting clinical trials for autologous cultured corneal epithelium and obtaining early approval3×
  5. 4Contract development and joint research with Fujifilm, Nidec, Osaka University and others2×
  6. 5Development of an Implementation Framework and Evaluation Methods for Regenerative Medicine2×
  7. 6Continued Losses and Negative Retained Earnings Carried Forward2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Japan Tissue Engineering's next results are scheduled for 2026-10-30. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.